Search

everythinglearnresearchcommunity

for

Search:↓

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Women with PCOS can lead healthy lives with proper diagnosis and treatment.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Laser pubic hair removal boosts self-esteem, body image, and sexual functions in women.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

The study concluded that the most common skin problems in women with PCOS are excess hair, acne, oily skin, hair loss, dark skin patches, and skin tags.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.